We are live on ! Find out more
SP

SIH Partners Portfolio holdings

AUM $7.58B
1-Year Est. Return 5.28%
This Fund
S&P 500
This Quarter Est. Return
+1.62%
1 Year Est. Return
+5.28%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$2.69B
AUM Growth
-$263M
Cap. Flow
-$386M
Cap. Flow %
-14.36%
Top 10 Hldgs %
65.93%
Holding
325
New
55
Increased
42
Reduced
42
Closed
171

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 20.42%
2 Materials 3.76%
3 Communication Services 3.25%
4 Technology 1.63%
5 Healthcare 1.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OPK icon
151
Opko Health
OPK
$921M
$91.6K ﹤0.01%
+69,419
New +$94.9K
LU icon
152
Lufax Holding
LU
$1.2B
$76.4K ﹤0.01%
27,400
IQ icon
153
iQIYI
IQ
$1.18B
$21.1K ﹤0.01%
11,900
-184,800
-94% -$332K
SENS icon
154
Senseonics Holdings Inc
SENS
$254M
$5.8K ﹤0.01%
+609
New +$7.11K
A icon
155
Agilent Technologies
A
$39.1B
-2,375
Closed -$278K
AAPL icon
156
CALL
Apple
AAPL
$4.89T
-10,000
Closed -$2.22M
ABBV icon
157
AbbVie
ABBV
$458B
-16,449
Closed -$3.45M
ABCL icon
158
AbCellera Biologics
ABCL
$1.62B
-17,163
Closed -$38.3K
ABSI icon
159
Absci
ABSI
$1.28B
-29,836
Closed -$74.9K
ABT icon
160
Abbott
ABT
$180B
-16,049
Closed -$2.13M
ABUS icon
161
Arbutus Biopharma
ABUS
$865M
-12,318
Closed -$43K
ACAD icon
162
Acadia Pharmaceuticals
ACAD
$4.25B
-10,756
Closed -$179K
ACLX
163
DELISTED
Arcellx
ACLX
-3,461
Closed -$227K
ADBE icon
164
Adobe
ADBE
$89.5B
-823
Closed -$316K
ADMA icon
165
ADMA Biologics
ADMA
$1.92B
-14,897
Closed -$296K
ADPT icon
166
Adaptive Biotechnologies
ADPT
$3.56B
-22,113
Closed -$164K
ADSK icon
167
Autodesk
ADSK
$44.3B
-4,000
Closed -$1.05M
AEM icon
168
Agnico Eagle Mines
AEM
$72.6B
-3,158
Closed -$342K
AGG icon
169
iShares Core US Aggregate Bond ETF
AGG
$138B
-74,780
Closed -$7.4M
AKRO
170
DELISTED
Akero Therapeutics
AKRO
-5,018
Closed -$203K
ALKS icon
171
Alkermes
ALKS
$8.82B
-10,234
Closed -$338K
ALLO icon
172
Allogene Therapeutics
ALLO
$601M
-13,747
Closed -$20.1K
ALNY icon
173
Alnylam Pharmaceuticals
ALNY
$36.3B
-7,959
Closed -$2.15M
ALVO icon
174
Alvotech
ALVO
$1.03B
-19,000
Closed -$184K
AMGN icon
175
Amgen
AMGN
$203B
-42,844
Closed -$13.3M

Similar funds

SIH Partners's Q2 2025 Portfolio in Review

As of Q2 2025, SIH Partners held 325 positions worth $2.69B, down 8.9% from $2.95B the previous quarter. Its ten largest holdings account for 66% of the portfolio.

SIH Partners withdrew a net $386M in Q2 2025, closing 171 positions and reducing 42 holdings. Its most notable exit was iShares JPMorgan USD Emerging Markets Bond ETF, an estimated $28.1M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 20% of assets, up from 14% a quarter earlier, followed by Materials and Communication Services.

Against the trend, SIH Partners opened a new position in Amrize Ltd worth $49.7M.

  • SIH Partners's largest Q2 2025 buy was Amrize Ltd: 1,003,159 shares worth $49.7M.
  • SIH Partners added most to Alibaba in Q2 2025, an estimated $127M increase.
  • SIH Partners's biggest Q2 2025 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $127M.
  • SIH Partners fully exited iShares JPMorgan USD Emerging Markets Bond ETF in Q2 2025, selling an estimated $28.1M.
  • SIH Partners's ten largest holdings make up 66% of its $2.69B portfolio in Q2 2025.
  • SIH Partners opened 55 new positions and closed 171 in Q2 2025.
  • SIH Partners's portfolio value fell 8.9% quarter-over-quarter to $2.69B.

Based on SIH Partners's 13F filing for Q2 2025, filed 14 Aug 2025.